Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2386443
Max Phase: Preclinical
Molecular Formula: C11H11N5O5
Molecular Weight: 293.24
Molecule Type: Small molecule
Associated Items:
ID: ALA2386443
Max Phase: Preclinical
Molecular Formula: C11H11N5O5
Molecular Weight: 293.24
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1c(C(=O)N/N=C/c2ccc([N+](=O)[O-])o2)[n+]([O-])cn1C
Standard InChI: InChI=1S/C11H11N5O5/c1-7-10(15(18)6-14(7)2)11(17)13-12-5-8-3-4-9(21-8)16(19)20/h3-6H,1-2H3,(H,13,17)/b12-5+
Standard InChI Key: RDULMDQEEDQVOS-LFYBBSHMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 293.24 | Molecular Weight (Monoisotopic): 293.0760 | AlogP: 0.23 | #Rotatable Bonds: 4 |
Polar Surface Area: 129.61 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 10 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.53 | CX Basic pKa: 0.60 | CX LogP: 0.45 | CX LogD: 0.42 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.28 | Np Likeness Score: -1.73 |
1. Pieczonka AM, Strzelczyk A, Sadowska B, Mlostoń G, Stączek P.. (2013) Synthesis and evaluation of antimicrobial activity of hydrazones derived from 3-oxido-1H-imidazole-4-carbohydrazides., 64 [PMID:23648974] [10.1016/j.ejmech.2013.04.023] |
Source(1):